top of page

Fragile X Syndrome (FXS)

Also called "Martin-Bell Syndrome"

or "Marker X Syndrome"

  • X-linked dominant genetic disorder caused by changes to the Fragile X Messenger Ribonucleoprotein 1 (FMR1) gene

    • The FMR1 gene, located on the X chromosome, normally contains between 5 and 44 CGG nucleotide-triplet repeats, although the number varies from person to person, but people with FXS can have more than 200 CGG repeats, which causes the FMR1 gene to "turn off"

      • The FMR1 gene makes a protein (FMRP) that is critical for brain development; FMRP is not produced, or produced in extremely limited amounts, in people with FXS​

        • Fragile X-Associated Disorders are characterized by changes to the FMR1 gene, but some FMRP is still produced

          • There are often abnormal numbers of CGG triplet repeats in the FMR1 gene​

  • The exact number of people affected with FXS is unknown and estimates vary

    • Affects an estimated 1 in 4,000-7,000 males and 1 in 6,000-11,000 females in the U.S.

      • More males are affected with FXS and have more significant symptoms, but more females seem to be carriers of altered FMR1 genes​

    • Affects people from all ethnic backgrounds

  • Symptoms:

    • Developmental delays

      • Sitting, walking, talking, etc. later than peers​​

    • Learning disabilities

    • Social and behavioral challenges 

    • Intellectual disabilities

      • Ranges from mild to severe in males; less common and less significant in females​

    • Males may have a large head, long face, protruding ears, and other physical characteristics

      • May not be apparent until after puberty​

    • Associated with Autism Spectrum Disorder (ASD)

  • Diagnosed by analyzing DNA acquired through a blood sample​

    • Looks for more than 200 CGG nucleotide triplets on the FMR1 gene​​

  • Most patients are diagnosed before the age of 2

  • No cure exists

    • Treatments aim to improve skills such as walking, talking, and social interaction

      • Early intervention is extremely important but treatment at any age can be beneficial​

    • Medications can be used to help manage behavioral challenges

 
Sources
Center for Disease Control (CDC)

NORD​

bottom of page